| Product Code: ETC9398204 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Bacteriophages Therapy Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Bacteriophages Therapy Market - Industry Life Cycle |
3.4 South Korea Bacteriophages Therapy Market - Porter's Five Forces |
3.5 South Korea Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 South Korea Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 South Korea Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 South Korea Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections driving the demand for alternative therapies like bacteriophage therapy. |
4.2.2 Growing awareness and acceptance of bacteriophage therapy among healthcare professionals and patients. |
4.2.3 Government initiatives and funding to support research and development in the field of bacteriophage therapy. |
4.3 Market Restraints |
4.3.1 Lack of standardized regulations and guidelines for the use of bacteriophages in therapy. |
4.3.2 Limited clinical evidence and research studies supporting the efficacy and safety of bacteriophage therapy. |
4.3.3 High costs associated with the production and purification of bacteriophages for therapy. |
5 South Korea Bacteriophages Therapy Market Trends |
6 South Korea Bacteriophages Therapy Market, By Types |
6.1 South Korea Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 South Korea Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 South Korea Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 South Korea Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 South Korea Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 South Korea Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 South Korea Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 South Korea Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 South Korea Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 South Korea Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 South Korea Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 South Korea Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 South Korea Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 South Korea Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 South Korea Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 South Korea Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 South Korea Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 South Korea Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 South Korea Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 South Korea Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 South Korea Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 South Korea Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 South Korea Bacteriophages Therapy Market Export to Major Countries |
7.2 South Korea Bacteriophages Therapy Market Imports from Major Countries |
8 South Korea Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on bacteriophage therapy in South Korea. |
8.2 Adoption rate of bacteriophage therapy in hospitals and healthcare facilities. |
8.3 Number of patents filed or granted for bacteriophage therapy-related technologies in South Korea. |
9 South Korea Bacteriophages Therapy Market - Opportunity Assessment |
9.1 South Korea Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 South Korea Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 South Korea Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 South Korea Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Bacteriophages Therapy Market - Competitive Landscape |
10.1 South Korea Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 South Korea Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here